600664:SHA
Harbin Pharmaceutical Group Co Ltd
CNÂ¥3.16
arrow_upward
+2.27%(+0.070) 1D
Jun 12, 3:00:00 PM GMT+8 · CNY
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 600664...
Open
CNÂ¥3.10
High
CNÂ¥3.18
Low
CNÂ¥3.07
Mkt. cap
7.96B
Avg. vol.
76.57M
Volume
40.26M
P/E ratio
25.69
52-wk high
CNÂ¥4.88
52-wk low
CNÂ¥3.05
EPS
CNÂ¥0.12
Shares outstanding
2.54B
No. of employees
10K
Open
CNÂ¥3.10
High
CNÂ¥3.18
Low
CNÂ¥3.07
Mkt. cap
7.96B
Avg. vol.
76.57M
Volume
40.26M
P/E ratio
25.69
52-wk high
CNÂ¥4.88
52-wk low
CNÂ¥3.05
EPS
CNÂ¥0.12
Shares outstanding
2.54B
No. of employees
10K
News stories
From sources across the web
The Motley Fool
·
10 minutes ago
Gold vs. the S&P 500: With Inflation at a 3-Year High, Which Does History Say Wins?
Barchart.com
·
41 minutes ago
When the AI Trade Collapses, These 3 S&P 500 Sectors Are Your Best Bet
TradingView
·
3 hours ago
S&P 500, SPY, VOO, IVV outlook: top news to watch this week
Profile
Harbin Pharmaceutical Group Co., Ltd. is a Chinese partially state-owned company engaged in the research & development, manufacture, and sale of pharmaceutical products. HPGC medication offerings include traditional Chinese medicine and biopharmaceuticals; its main offerings include antibiotics, including amoxicillin and penicillin, and dietary supplements, including zinc gluconate and calcium gluconate.
The company owns both Renmintongtai, a drugstore chain and medical wholesaler for the domestic market, and GNC, a U.S.-based international retailer of supplements and wellness products. Wikipedia
About Harbin Pharmaceutical Group Co Ltd
AI content may include mistakes. Learn more